Cleveland Clinic virology researchers have found that a specific protein modification to the immune protein MDA5 is key to ...

Australian scientists developed a novel antiviral that targets the SARS-CoV-2 PLpro enzyme, showing strong preclinical ...

The Trump administration cut $12.6 million in research funding for the University of Wisconsin-Madison, including coronavirus ...

The following is a summary of “A viro-immunological model to characterize the antiviral effect of molnupiravir in ...

Cocrystal Pharma, Inc. is a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication process of influenza viruses, coronaviruses ...